15-Keto prostaglandin E1
CAS: 22973-19-9
Rif. 3D-FK24783
1mg | Fuori produzione | ||
2mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- (11a,13E)-11-Hydroxy-9,15-dioxo-prost-13-en-1-oic acid3-Hydroxy-5-oxo-2-(3-oxo-1-octenyl)-cyclopentaneheptanoic acid15-Keto-PGE1
- (11α,13E)-11-Hydroxy-9,15-dioxoprost-13-en-1-oic acid
- 15-Keto-PGE<sub>1</sub>
- 15-Ketoprostaglandin E<sub>1</sub>
- 15-Oxo-PGE<sub>1</sub>
- 15-Oxoprostaglandin E<sub>1</sub>
- 15-keto-Prostaglandin E<sub>1</sub>
- Cyclopentaneheptanoic acid, 3-hydroxy-5-oxo-2-(3-oxo-1-octenyl)-
- Cyclopentaneheptanoic acid, 3-hydroxy-5-oxo-2-(3-oxo-1-octenyl)-, stereoisomer
- NotAvailable
- Vedi altri sinonimi
- Prost-13-en-1-oic acid, 11-hydroxy-9,15-dioxo-, (11α,13E)-
- U 22409
15-Keto prostaglandin E1 is a prostanoic acid with 15-hydroxy group in the middle of the molecule. It is a metabolite of prostaglandin and has been shown to have antioxidative activity, which may be related to its ability to inhibit platelet aggregation. 15-Keto prostaglandin E1 has also been found to increase insulin sensitivity, reduce blood pressure, and inhibit neutrophil activation. This compound has potential clinical relevance for prevention and treatment of many diseases such as cancer, coronary heart diseases, and inflammatory disorders.